Diagnostic Testing Fund – Adult Oncology: Solid Tumors

This fund supports individuals with solid tumors, such as breast, lung, or colorectal cancer, by providing access to essential diagnostic testing — including genetic and biomarker testing like HER2, KRAS, and EGFR. These tools help identify tumor subtypes and guide treatment decisions, ensuring patients are matched with the most effective, personalized therapies. Precision diagnostics like these are especially critical for those who may not have access to large cancer centers or specialized oncology care.